Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.

7/435 Coincidencias para
“Collagen proportionate area”

“Collagen proportionate area” Borrar todo
  1. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Review

    Parikh P et al. · Ann Transl Med · 2017 Coinc. 100

    Chronic hepatitis B virus (HBV) infection is a major cause of liver…

    FibroTest HBV

  2. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. Review

    Lombardi R et al. · World J Gastroenterol · 2015 Coinc. 93

    Alcoholic liver disease (ALD) consists of a broad spectrum of disorders, ranging…

    FibroTest Alcohol

  3. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. Review

    Stasi C et al. · World J Gastroenterol · 2016 Coinc. 86

    …However, both serum markers and transient elastography still have "grey area" values…

    FibroTest HCV

  4. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

    Lemoine M et al. · J Acquir Immune Defic Syndr · 2019 Coinc. 79

    …Performance was considered as good if area under a receiver operating characteristic…

    FibroTest NashTest SteatoTest HIV

  5. Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.

    Patel K et al. · Aliment Pharmacol Ther · 2016 Coinc. 72

    …Serum FS and paired biopsies, with both collagen and α-SMA morphometry…

    FibroTest HCV

  6. Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

    Poynard T et al. · Diagnostics (Basel) · 2025 Coinc. 65

    …comparator (five-tiers), the weighted area under the characteristic curve (wAUROC) instead…

    FibroTest-T2D Metabolic

  7. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication

    European Association for Study of Liver et al. · J Hepatol · 2015 Coinc. 58

    FibroTest Alcohol HBV HCV +3

Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.